Neogenomics Inc (NASDAQ:NEO)

4.78
Delayed Data
As of 9:56am ET
 +0.06 / +1.27%
Today’s Change
2.95
Today|||52-Week Range
6.10
+14.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-1.2M65.0K2.0M--
 
 
 
 
Depreciation2.1M3.8M4.4M--
 
 
 
 
Total Other Cash Flow3.1M3.9M3.7M--
 
 
 
 
Funds From Operations4.0M7.8M10.1M--
 
 
 
 
Funds From/For Other Operating Expenses3.9M8.3M7.9M--
 
 
 
 
Net Cash Flow - Operating Activities69.0K-492.0K2.2M9.5M
 
 
 
 
 
 
InvestingCapital Expenditures-897.0K-2.6M-2.0M--
 
 
 
 
Net Cash Flow Investing-897.0K-3.7M-2.0M-9.6M
 
 
 
 
 
 
FinancingShort Term Borrowings456.0K4.6M-4.2M--
 
 
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-1.6M-2.2M-2.6M--
 
 
 
 
Net Proceeds Stock Sale3.5M511.0K9.5M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00500.0K0.00--
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing2.4M3.4M2.8M29.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash1.5M-760.0K3.0M28.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account